Foreign-Trade Zone (FTZ) 93-Raleigh/Durham, North Carolina; Notification of Proposed Production Activity; GlaxoSmithKline, PLC (Pharmaceutical Products); Zebulon, North Carolina, 70531-70532 [2013-28353]

Download as PDF Federal Register / Vol. 78, No. 228 / Tuesday, November 26, 2013 / Notices Implementing Procedures (7 CFR part 372). Done in Washington, DC, this 20th day of November 2013. Kevin Shea, Administrator, Animal and Plant Health Inspection Service. [FR Doc. 2013–28322 Filed 11–25–13; 8:45 am] BILLING CODE 3410–34–P DEPARTMENT OF AGRICULTURE Forest Service Ashley Resource Advisory Committee Forest Service, USDA. Notice of meeting cancellation. AGENCY: ACTION: The cancelled meeting was to be held at the Ashley National Forest Supervisor’s Office, Conference Room, 355 North Vernal Avenue, Vernal, Utah. Written comments concerning this cancellation may be submitted as described under FOR FURTHER INFORMATION CONTACT. All comments, including names and addresses when provided, are placed in the record and are available for public inspection and copying. The public may inspect comments received at the Ashley National Forest Supervisor’s Office. Please call ahead to facilitate entry into the building to view comments. FOR FURTHER INFORMATION CONTACT: Louis Haynes, RAC Coordinator, by phone at 435–781–5105 or email at: lhaynes@fs.fed.us. Individuals who use telecommunication devices for the deaf (TDD) may call the Federal Information Relay Service (FIRS) at 1–800–877–8339 between 8:00 a.m. and 8:00 p.m., Eastern Standard Time, Monday through Friday. ADDRESSES: The Ashley Resource Advisory Committee (RAC) meeting scheduled on the date below is cancelled. The meeting was scheduled to meet in Vernal, Utah. The RAC is authorized under the Secure Rural Schools and Community SelfDetermination Act (the Act) (Pub. L. 110–343) and operates in compliance with the Federal Advisory Committee Act (FACA) (Pub. L. 92–463). DATES: The cancelled meeting was scheduled for 6:00 p.m. on February 28, 2013. SUMMARY: Dated: November 5, 2013. John R. Erickson, Forest Supervisor. [FR Doc. 2013–28189 Filed 11–25–13; 8:45 am] 70531 DEPARTMENT OF COMMERCE Economic Development Administration Notice of Petitions by Firms for Determination of Eligibility To Apply for Trade Adjustment Assistance Economic Development Administration, Department of Commerce. AGENCY: Notice and opportunity for public comment. ACTION: Pursuant to Section 251 of the Trade Act 1974, as amended (19 U.S.C. 2341 et seq.), the Economic Development Administration (EDA) has received petitions for certification of eligibility to apply for Trade Adjustment Assistance from the firms listed below. Accordingly, EDA has initiated investigations to determine whether increased imports into the United States of articles like or directly competitive with those produced by each of these firms contributed importantly to the total or partial separation of the firm’s workers, or threat thereof, and to a decrease in sales or production of each petitioning firm. BILLING CODE 3410–11–M LIST OF PETITIONS RECEIVED BY EDA FOR CERTIFICATION ELIGIBILITY TO APPLY FOR TRADE ADJUSTMENT ASSISTANCE [11/07/2013 through 11/20/2013] Date accepted for investigation Firm name Firm address DryCase, LLC ......................................... 349 Military Cutoff Road, Wilmington, NC 28405. 1521 East McFadden Suite F, Santa Ana, CA 92705. emcdonald on DSK67QTVN1PROD with NOTICES Benchmark Clothing (dba—Benchmark Benchmark FR). Company, Clothing Inc. and Any party having a substantial interest in these proceedings may request a public hearing on the matter. A written request for a hearing must be submitted to the Trade Adjustment Assistance for Firms Division, Room 71030, Economic Development Administration, U.S. Department of Commerce, Washington, DC 20230, no later than ten (10) calendar days following publication of this notice. Please follow the requirements set forth in EDA’s regulations at 13 CFR 315.9 for procedures to request a public hearing. The Catalog of Federal Domestic Assistance official number and title for the program under which these petitions are submitted is 11.313, Trade Adjustment Assistance for Firms. VerDate Mar<15>2010 18:04 Nov 25, 2013 Jkt 232001 11/08/2013 11/08/2013 Dated: November 20, 2013. Michael DeVillo, Eligibility Examiner. [FR Doc. 2013–28302 Filed 11–25–13; 8:45 am] BILLING CODE 3510–WH–P DEPARTMENT OF COMMERCE Foreign Trade Zones Board [B–98–2013] Foreign-Trade Zone (FTZ) 93—Raleigh/ Durham, North Carolina; Notification of Proposed Production Activity; GlaxoSmithKline, PLC (Pharmaceutical Products); Zebulon, North Carolina The Triangle J Council of Governments, grantee of FTZ 93, submitted a notification of proposed PO 00000 Frm 00004 Fmt 4703 Sfmt 4703 Product(s) The firm manufactures waterproof bags for electronic devices. The firm manufacturers flame resistant garments. production activity to the FTZ Board on behalf of GlaxoSmithKline, PLC (GlaxoSmithKline), located in Zebulon, North Carolina. The notification conforming to the requirements of the regulations of the FTZ Board (15 CFR 400.22) was received on November 18, 2013. The GlaxoSmithKline facility is located within Site 6 of FTZ 93. The facility is used for the production and packaging of pharmaceutical products. Pursuant to 15 CFR 400.14(b), FTZ activity would be limited to the specific foreign-status materials and components and specific finished products listed in the submitted notification (as described below) and subsequently authorized by the FTZ Board. Production under FTZ procedures could exempt GlaxoSmithKline from E:\FR\FM\26NON1.SGM 26NON1 emcdonald on DSK67QTVN1PROD with NOTICES 70532 Federal Register / Vol. 78, No. 228 / Tuesday, November 26, 2013 / Notices customs duty payments on the foreign status components used in export production. On its domestic sales, GlaxoSmithKline would be able to choose the duty rates during customs entry procedures that apply to inhalers, tablets, and capsules which treat a variety of medical conditions (duty rates range from free to 6.4%) for the foreign status inputs noted below. Customs duties also could possibly be deferred or reduced on foreign status production equipment. The finished products include devices such as respiratory placebo inhalers, Relenza anti-viral inhalers, Seretide/ Advair, Serevent and Flovent diskus respiratory inhalers, Advair and Ventolin HFA respiratory inhalers, and the following tablets and capules— Lovaza antihyperlipidemic, Paxil depression, Avandamet metabolic, Avandary metabolic, Avandia metabolic, Lamictal central nervous system (CNS), Potiga CNS, Amerge CNS, Horizant CNS, Imitrex CNS, Lamictal ODT CNS, Requip/Requip XL CNS, Treximet CNS, Telzir anti-viral, Valtrex anti-viral, Zovirax anti-viral, Wellbutrin/Buproprion depression, Zantac gastrointestinal (GI), Zofran GI, Votrient urology, Coreg CR cardiovascular, Rythmol cardiovascular, Innopran XL hypertension, Jalyn urology, Avodart urology, Lanoxin cardiovascular, Malarone anti-malarial, Promacta immune thrombocytopenia (ITP), and Tykerb oncology. The components and materials sourced from abroad include corn starch, carnuba wax, lactose monohydrate, fluticasone/salmeterol placebo diskus (a type of inhaler), respiratory placebo inhaler, silica colloidal anhydrous, precipitated calcium carbonate, pharmaceutical talc, zephex 134a propellant, mannitol, magnesium stearate, stearic acid, potassium sorbate, propafenon hcl, bupropion hydrochloride, melphalan, albuterol sufate, salbuterol sulfate, salmeterol, vilanterol trifenatate, umeclidinium api, paracetamol, ezogabine (retigabine), paracetamol, metformin hydrochloride, ranitidine hydrochloride, zanamivir, ondansetron hydrochloride, abacavir sulfate, valacyclovir hydrochloride, lamotrigine, rosiglitazone maleate, paroxetine hydrochloride, lamivudine, zidovudine, pazopanib, fluticasone propionate, fluticasone furoate, dutasteride, Lovaza capsules, breo ellipta inhalers, avodart capsules, flovent diskus, Paxil tablets, lexiva oral suspension, sumatriptan succinate/naproxen (Treximet), abacavir/lamivudine tablets (epzicom) tablets, atovaquone and proguanil hcl tablets, combivir tablets, dolutegravir VerDate Mar<15>2010 18:04 Nov 25, 2013 Jkt 232001 tablets, epivir tablets, epzicom tablets, malarone tablets, ziagen tablets, Zantac tablets, mekinist tablets, trametinib tablets, pazopanib tablets, tafinlar capsules, votrient tablets, coreg cr capsules, flolan for injection, propafenon sr, Rythmol (proafenon) sr, Amerge tablets, imigran injection, imitrex bulk pack, sumatriptan succinate 85mg/naproxen, lamictal, parnate tablets, ondansetron odt bulk, requip tablets, soriatane (acitretin) capsules, Zofran, Ventolin actuator dose counter, Advair diskus, Advair diskus inhalation powder, fluticasone/ salmeterol aerosol inhalers, Ventolin samples, Seretide, argatroban, arixtra, Avandamet tablets, Avandia tablets, dutasteride-tamsulosin hcl fdc capsules, eltrombopag, flolan sterile diluent, Jalyn fixed dose combination capsules, panadol tablets, opadry (an excipient), starch pregel, Avandamet placebo tablets, placebo diskus, nasal spray demo pack, respiratory placebo, triacetin, crospovidone, povidone, spectracel, alginic acid ep, 20 micron aluminum powder, empty aerosol cans, pressure can spray valves, diskus subassemblies, multi-dose powder inhalers, novel dry powder inhalers, multi-dose powder inhaler subassembly and placebo, multi-dose powder inhaler diskus devices, actuators—and their dose counters and assemblies (duty rates range from free to 6.5%). Public comment is invited from interested parties. Submissions shall be addressed to the FTZ Board’s Executive Secretary at the address below. The closing period for their receipt is January 6, 2014. A copy of the notification will be available for public inspection at the Office of the Executive Secretary, Foreign-Trade Zones Board, Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW., Washington, DC 20230–0002, and in the ‘‘Reading Room’’ section of the FTZ Board’s Web site, which is accessible via www.trade.gov/ftz. For further information, contact Diane.Finver@trade.gov or (202) 482– 1367. Dated: November 19, 2013. Andrew McGilvray, Executive Secretary. [FR Doc. 2013–28353 Filed 11–25–13; 8:45 am] BILLING CODE 3510–DS–P PO 00000 Frm 00005 Fmt 4703 Sfmt 4703 DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [B–99–2013] Notification of Proposed Production Activity, Hitachi Automotive Systems Americas, Inc., Subzone 29F, (Automotive Electric-Hybrid Drive System Components), Harrodsburg, Kentucky The Louisville and Jefferson County Riverport Authority, grantee of FTZ 29, submitted a notification of proposed production activity to the FTZ Board on behalf of Hitachi Automotive Systems Americas, Inc. (HIAMS–HK), operator of Subzone 29F, at its facilities located in Harrodsburg, Kentucky. The notification conforming to the requirements of the regulations of the FTZ Board (15 CFR 400.22) was received on November 12, 2013. HIAMS–HK already has authority to produce various automotive components, including mass air sensors, throttle bodies and chambers, starter motors, motor/generator units, alternators, distributors, other static converters, inverter modules, rotors/ stators, batteries, ignition coils, sensors and modules, fuel injectors, emissions control equipment, valves, pumps, and electronic control units for engines and transmissions within Subzone 29F. The current request would add finished products (lithium-ion hybrid battery pack assemblies, electrical power steering modules, and electronic torque, traction and transmission control modules) and certain foreign components to the scope of authority. Pursuant to 15 CFR 400.14(b), FTZ activity would be limited to the specific foreign-status components and specific finished products described in the submitted notification (as described below) and subsequently authorized by the FTZ Board. Production under FTZ procedures could exempt HIAMS–HK from customs duty payments on the foreign status components used in export production. On its domestic sales, HIAMS–HK would be able to choose the duty rates during customs entry procedures that apply to lithium-ion hybrid battery pack assemblies, rotors A&B, stators A&B, electrical power steering modules, and electronic torque, traction and transmission control modules (free– 3.4%) for the foreign status inputs noted below and in the existing scope of authority. Customs duties also could possibly be deferred or reduced on foreign status production equipment. The components and materials sourced from abroad include: Plastic E:\FR\FM\26NON1.SGM 26NON1

Agencies

[Federal Register Volume 78, Number 228 (Tuesday, November 26, 2013)]
[Notices]
[Pages 70531-70532]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-28353]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign Trade Zones Board

[B-98-2013]


Foreign-Trade Zone (FTZ) 93--Raleigh/Durham, North Carolina; 
Notification of Proposed Production Activity; GlaxoSmithKline, PLC 
(Pharmaceutical Products); Zebulon, North Carolina

    The Triangle J Council of Governments, grantee of FTZ 93, submitted 
a notification of proposed production activity to the FTZ Board on 
behalf of GlaxoSmithKline, PLC (GlaxoSmithKline), located in Zebulon, 
North Carolina. The notification conforming to the requirements of the 
regulations of the FTZ Board (15 CFR 400.22) was received on November 
18, 2013.
    The GlaxoSmithKline facility is located within Site 6 of FTZ 93. 
The facility is used for the production and packaging of pharmaceutical 
products. Pursuant to 15 CFR 400.14(b), FTZ activity would be limited 
to the specific foreign-status materials and components and specific 
finished products listed in the submitted notification (as described 
below) and subsequently authorized by the FTZ Board.
    Production under FTZ procedures could exempt GlaxoSmithKline from

[[Page 70532]]

customs duty payments on the foreign status components used in export 
production. On its domestic sales, GlaxoSmithKline would be able to 
choose the duty rates during customs entry procedures that apply to 
inhalers, tablets, and capsules which treat a variety of medical 
conditions (duty rates range from free to 6.4%) for the foreign status 
inputs noted below. Customs duties also could possibly be deferred or 
reduced on foreign status production equipment.
    The finished products include devices such as respiratory placebo 
inhalers, Relenza anti-viral inhalers, Seretide/Advair, Serevent and 
Flovent diskus respiratory inhalers, Advair and Ventolin HFA 
respiratory inhalers, and the following tablets and capules--Lovaza 
antihyperlipidemic, Paxil depression, Avandamet metabolic, Avandary 
metabolic, Avandia metabolic, Lamictal central nervous system (CNS), 
Potiga CNS, Amerge CNS, Horizant CNS, Imitrex CNS, Lamictal ODT CNS, 
Requip/Requip XL CNS, Treximet CNS, Telzir anti-viral, Valtrex anti-
viral, Zovirax anti-viral, Wellbutrin/Buproprion depression, Zantac 
gastrointestinal (GI), Zofran GI, Votrient urology, Coreg CR 
cardiovascular, Rythmol cardiovascular, Innopran XL hypertension, Jalyn 
urology, Avodart urology, Lanoxin cardiovascular, Malarone anti-
malarial, Promacta immune thrombocytopenia (ITP), and Tykerb oncology.
    The components and materials sourced from abroad include corn 
starch, carnuba wax, lactose monohydrate, fluticasone/salmeterol 
placebo diskus (a type of inhaler), respiratory placebo inhaler, silica 
colloidal anhydrous, precipitated calcium carbonate, pharmaceutical 
talc, zephex 134a propellant, mannitol, magnesium stearate, stearic 
acid, potassium sorbate, propafenon hcl, bupropion hydrochloride, 
melphalan, albuterol sufate, salbuterol sulfate, salmeterol, vilanterol 
trifenatate, umeclidinium api, paracetamol, ezogabine (retigabine), 
paracetamol, metformin hydrochloride, ranitidine hydrochloride, 
zanamivir, ondansetron hydrochloride, abacavir sulfate, valacyclovir 
hydrochloride, lamotrigine, rosiglitazone maleate, paroxetine 
hydrochloride, lamivudine, zidovudine, pazopanib, fluticasone 
propionate, fluticasone furoate, dutasteride, Lovaza capsules, breo 
ellipta inhalers, avodart capsules, flovent diskus, Paxil tablets, 
lexiva oral suspension, sumatriptan succinate/naproxen (Treximet), 
abacavir/lamivudine tablets (epzicom) tablets, atovaquone and proguanil 
hcl tablets, combivir tablets, dolutegravir tablets, epivir tablets, 
epzicom tablets, malarone tablets, ziagen tablets, Zantac tablets, 
mekinist tablets, trametinib tablets, pazopanib tablets, tafinlar 
capsules, votrient tablets, coreg cr capsules, flolan for injection, 
propafenon sr, Rythmol (proafenon) sr, Amerge tablets, imigran 
injection, imitrex bulk pack, sumatriptan succinate 85mg/naproxen, 
lamictal, parnate tablets, ondansetron odt bulk, requip tablets, 
soriatane (acitretin) capsules, Zofran, Ventolin actuator dose counter, 
Advair diskus, Advair diskus inhalation powder, fluticasone/salmeterol 
aerosol inhalers, Ventolin samples, Seretide, argatroban, arixtra, 
Avandamet tablets, Avandia tablets, dutasteride-tamsulosin hcl fdc 
capsules, eltrombopag, flolan sterile diluent, Jalyn fixed dose 
combination capsules, panadol tablets, opadry (an excipient), starch 
pregel, Avandamet placebo tablets, placebo diskus, nasal spray demo 
pack, respiratory placebo, triacetin, crospovidone, povidone, 
spectracel, alginic acid ep, 20 micron aluminum powder, empty aerosol 
cans, pressure can spray valves, diskus subassemblies, multi-dose 
powder inhalers, novel dry powder inhalers, multi-dose powder inhaler 
subassembly and placebo, multi-dose powder inhaler diskus devices, 
actuators--and their dose counters and assemblies (duty rates range 
from free to 6.5%).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the FTZ Board's Executive Secretary at the 
address below. The closing period for their receipt is January 6, 2014.
    A copy of the notification will be available for public inspection 
at the Office of the Executive Secretary, Foreign-Trade Zones Board, 
Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW., 
Washington, DC 20230-0002, and in the ``Reading Room'' section of the 
FTZ Board's Web site, which is accessible via www.trade.gov/ftz.
    For further information, contact 
Diane.Finver[com x mat]trade.gov or (202) 482-1367.

    Dated: November 19, 2013.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2013-28353 Filed 11-25-13; 8:45 am]
BILLING CODE 3510-DS-P